Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Wilkinson

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Vaccine|August 27, 2019
Non-typeable Haemophilus influenzae protein vaccine in adults with COPD: A phase 2 clinical trialTom M A Wilkinson, Stuart Schembri, Christopher Brightling, et al.
Respiratory Research|July 30, 2018
Impact of radiologically stratified exacerbations: insights into pneumonia aetiology in COPDNicholas P Williams, Kristoffer Ostridge, Jeanne-Marie Devaster, et al.
ERJ Open Research|March 30, 2023
Nebulised interferon-β1a (SNG001) in hospitalised COVID-19: SPRINTER phase III studyPhillip D Monk, Jody L Brookes, Victoria J Tear, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 31, 2008
Plasma homocysteine is elevated in COPD patients and is related to COPD severityTerence A R Seemungal, Johanna Cho Fook Lun, Gershwin Davis, et al.
American Journal of Respiratory and Critical Care Medicine|September 28, 2022
Antiviral Responses of Tissue-resident CD49a<sup>+</sup> Lung Natural Killer Cells Are Dysregulated in Chronic Obstructive Pulmonary DiseaseGrace E Cooper, Jemma Mayall, Chantal Donovan, et al.
Respiratory Research|May 22, 2021
Risk factors for persistent abnormality on chest radiographs at 12-weeks post hospitalisation with PCR confirmed COVID-19T J M Wallis, E Heiden, J Horno, et al.
American Journal of Respiratory and Critical Care Medicine|December 17, 2020
Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal AnalysisZhang Wang, Nicholas Locantore, Koirobi Haldar, et al.
ERJ Open Research|March 1, 2019
Drivers of year-to-year variation in exacerbation frequency of COPD: analysis of the AERIS cohortTom M A Wilkinson, Emmanuel Aris, Simon C Bourne, et al.
The Lancet. Respiratory Medicine|January 13, 2022
Non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b trialStefan Andreas, Marco Testa, Laurent Boyer, et al.
The European Respiratory Journal|July 1, 2022
Towards an artificial human lung: modelling organ-like complexity to aid mechanistic understandingMaria Victoria Humbert, Cosma Mirella Spalluto, Joseph Bell, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Vaccine|August 27, 2019
Non-typeable Haemophilus influenzae protein vaccine in adults with COPD: A phase 2 clinical trialTom M A Wilkinson, Stuart Schembri, Christopher Brightling, et al.
Respiratory Research|July 30, 2018
Impact of radiologically stratified exacerbations: insights into pneumonia aetiology in COPDNicholas P Williams, Kristoffer Ostridge, Jeanne-Marie Devaster, et al.
ERJ Open Research|March 30, 2023
Nebulised interferon-β1a (SNG001) in hospitalised COVID-19: SPRINTER phase III studyPhillip D Monk, Jody L Brookes, Victoria J Tear, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 31, 2008
Plasma homocysteine is elevated in COPD patients and is related to COPD severityTerence A R Seemungal, Johanna Cho Fook Lun, Gershwin Davis, et al.
American Journal of Respiratory and Critical Care Medicine|September 28, 2022
Antiviral Responses of Tissue-resident CD49a<sup>+</sup> Lung Natural Killer Cells Are Dysregulated in Chronic Obstructive Pulmonary DiseaseGrace E Cooper, Jemma Mayall, Chantal Donovan, et al.
Respiratory Research|May 22, 2021
Risk factors for persistent abnormality on chest radiographs at 12-weeks post hospitalisation with PCR confirmed COVID-19T J M Wallis, E Heiden, J Horno, et al.
American Journal of Respiratory and Critical Care Medicine|December 17, 2020
Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal AnalysisZhang Wang, Nicholas Locantore, Koirobi Haldar, et al.
ERJ Open Research|March 1, 2019
Drivers of year-to-year variation in exacerbation frequency of COPD: analysis of the AERIS cohortTom M A Wilkinson, Emmanuel Aris, Simon C Bourne, et al.
The Lancet. Respiratory Medicine|January 13, 2022
Non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b trialStefan Andreas, Marco Testa, Laurent Boyer, et al.
The European Respiratory Journal|July 1, 2022
Towards an artificial human lung: modelling organ-like complexity to aid mechanistic understandingMaria Victoria Humbert, Cosma Mirella Spalluto, Joseph Bell, et al.
Pageof 12